The latest price target for Definitive Healthcare (NASDAQ:DH) was reported by Needham on January 16, 2025. The analyst firm set a price target for $0.00 expecting DH to fall to within 12 months (a possible -100.00% downside). 23 analyst firms have reported ratings in the last year.

The latest analyst rating for Definitive Healthcare (NASDAQ:DH) was provided by Needham, and Definitive Healthcare reiterated their hold rating.

The last upgrade for Definitive Healthcare Corp happened on February 24, 2022 when Canaccord Genuity raised their price target to $28. Canaccord Genuity previously had a hold for Definitive Healthcare Corp.

The last downgrade for Definitive Healthcare Corp happened on January 13, 2025 when Barclays changed their price target from $4 to $4 for Definitive Healthcare Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Definitive Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Definitive Healthcare was filed on January 16, 2025 so you should expect the next rating to be made available sometime around January 16, 2026.

While ratings are subjective and will change, the latest Definitive Healthcare (DH) rating was a reiterated with a price target of $0.00 to $0.00. The current price Definitive Healthcare (DH) is trading at is $4.83, which is out of the analyst’s predicted range.